Effects of Arg16Gly polymorphism in ADRB2 gene on responses to salmeterol or montelukast added to inhaled corticosteroids in Japanese asthmatic subjects
S. Konno, H. Makita, N. Hizawa, K. Shimizu, F. Kokubu, T. Saito, T. Endo, H. Ninomiya, H. Iijima, N. Kaneko, M. Nishimura (Sapporo, Tsukuba, Yokohama, Toukai, Higashiibaragi, Noda, Kamogawa, Japan)
Source: Annual Congress 2012 - Asthma treatment: efficacy and safety
Session: Asthma treatment: efficacy and safety
Session type: Thematic Poster Session
Number: 2089
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Konno, H. Makita, N. Hizawa, K. Shimizu, F. Kokubu, T. Saito, T. Endo, H. Ninomiya, H. Iijima, N. Kaneko, M. Nishimura (Sapporo, Tsukuba, Yokohama, Toukai, Higashiibaragi, Noda, Kamogawa, Japan). Effects of Arg16Gly polymorphism in ADRB2 gene on responses to salmeterol or montelukast added to inhaled corticosteroids in Japanese asthmatic subjects. Eur Respir J 2012; 40: Suppl. 56, 2089
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Arg16Gly polymorphism of the β2 -adrenergic receptor gene does not modulate clinical response to salmeterol in subjects with asthmaSource: Annual Congress 2008 - New mechanisms in the pathogenesis of asthma and its response to treatment Year: 2008
Characterization of asthma exacerbations by Arg16Gly genotype in subjects with asthma receiving salmeterol alone or with fluticasone propionate Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy Year: 2008
Lack of effect of promoter, coding and 3‘ polymorphisms of the β2 -adrenergic receptor (ADRB2 ) on the clinical response to salmeterol alone or with fluticasone propionate in subjects with asthma Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy Year: 2008
The influence of β2 adrenoceptor polymorphisms on the response to formoterol, montelukast or higher dose budesonide in patients with uncontrolled asthma despite low dose budesonide Source: Annual Congress 2004 - Further pharmacological and clinical evidence for using long-acting β-agonists with inhaled corticosteroids Year: 2004
Comparison of add-on of leukotriene receptor antagonist vs. long-acting beta2-agonist on FeNO in asthmatic children on regular inhaled budesonide Source: Eur Respir J 2002; 20: Suppl. 38, 431s Year: 2002
Salmeterol response is not affected by beta2 -adrenergic receptor genotype in patients with persistent asthma Source: Eur Respir J 2005; 26: Suppl. 49, 505s Year: 2005
Effect of montelukast or salmeterol added to inhaled fluticasone on response to albuterol in children with exercise-induced bronchoconstriction Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009
Assessment of asthma control in asthmatic patients Brazilian carriers of the Arg16Gly polymorphism of the β2 adrenorreceptor gene Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma Year: 2009
ADRB2 Gly16Arg polymorphism, asthma control and lung function decline Source: Eur Respir J 2011; 38: 1029-1035 Year: 2011
The gln27 beta adrenoceptor polymorphism is associated with bronchodilator reversibility in subjects with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 96s Year: 2002
The linkage of bronchial hyperreactivity with Arg16Gly and Gln27Glu polymorphisms of ß2 -adrenoreceptors of patients with atopic bronchial asthma in Kyrgyz nation Source: Eur Respir J 2006; 28: Suppl. 50, 650s Year: 2006
Influence of ADRB2 gene polymorphism on cold airway hyperresponsiveness and asthma control depending on inhaled glucocorticoids use Source: Annual Congress 2012 - Gene-environment treatment and asthma Year: 2012
ADRB2 haplotypes and risk of exacerbations in asthmatic children and young adults treated with long-acting ß2-agonists: A meta-analysis in the PiCA consortium Source: International Congress 2019 – Genes and environment Year: 2019
Effect of montelukast added to inhaled steroids on exhaled NO in asthmatic children Source: Eur Respir J 2001; 18: Suppl. 33, 40s Year: 2001
Differences in bronchoprotective subsensitivity between formoterol (FM) and salmeterol (SM) are associated with β2 -adrenoceptor polymorphism Source: Eur Respir J 2002; 20: Suppl. 38, 306s Year: 2002
Effect of long-acting ß-agonist on bronchodilator response in children with asthma Source: Eur Respir J, 56 (3) 1902010; 10.1183/13993003.02010-2019 Year: 2020
Association of β2 -adrenoceptor genotypes with bronchodilatory effect of tiotropium in COPD Source: Annual Congress 2008 - Recent advances in the pathogenesis and treatment of asthma and COPD Year: 2008
Effects of procaterol or salmeterol added to maintenance tiotropium therapy on small airway functions in COPD patients Source: Annual Congress 2010 - COPD: management Year: 2010
Additional anti-inflammatory effects of inhaled budesonide/formoterol over inhaled budesonide in subjects with atopic asthma Source: Eur Respir J 2006; 28: Suppl. 50, 441s Year: 2006
The linkage of Arg16Gly polymorphism of β2 adrenoreceptor with expression of reversibility of bronchial obstruction of patients with atopic bronchial asthma in Kyrgyz nation Source: Eur Respir J 2006; 28: Suppl. 50, 236s Year: 2006